Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sowter, H. M.
Right arrow Articles by Harris, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sowter, H. M.
Right arrow Articles by Harris, A. L.
[Cancer Research 63, 6130-6134, October 1, 2003]
© 2003 American Association for Cancer Research


Advances in Brief

Predominant Role of Hypoxia-Inducible Transcription Factor (Hif)-1{alpha} versus Hif-2{alpha} in Regulation of the Transcriptional Response to Hypoxia1

Heidi M. Sowter, Raju Raval, John Moore, Peter J. Ratcliffe and Adrian L. Harris2

Cancer Research UK, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DU [H. M. S., J. M., A. L. H.], and Wellcome Trust Centre for Human Genetics, Oxford OX3 7BN [R. R., P. J. R.], United Kingdom

Tumor hypoxia induces the up-regulation of a gene program associated with angiogenesis, glycolysis, adaptation to pH, and apoptosis via the hypoxia-inducible transcription factors (Hifs) 1 and 2. Disruption of this pathway has been proposed as a cancer therapy. Here, we use short interfering RNAs to compare specific inactivation of Hif-1{alpha} or Hif-2{alpha} and show markedly different cell type-specific effects on gene expression and cell migration. Remarkably, among a panel of hypoxia-inducible genes, responses were critically dependent on Hif-1 {alpha} but not Hif-2 {alpha} in both endothelial and breast cancer cells but critically dependent on Hif-2 {alpha} in renal carcinoma cells.




This article has been cited by other articles:


Home page
Cancer Res.Home page
A. Taguchi, K. Yanagisawa, M. Tanaka, K. Cao, Y. Matsuyama, H. Goto, and T. Takahashi
Identification of Hypoxia-Inducible Factor-1{alpha} as a Novel Target for miR-17-92 MicroRNA Cluster
Cancer Res., July 15, 2008; 68(14): 5540 - 5545.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Basu, A. G. Contreras, D. Datta, E. Flynn, L. Zeng, H. T. Cohen, D. M. Briscoe, and S. Pal
Overexpression of Vascular Endothelial Growth Factor and the Development of Post-Transplantation Cancer
Cancer Res., July 15, 2008; 68(14): 5689 - 5698.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. A. Gerber and J. S. Pober
IFN-{alpha} Induces Transcription of Hypoxia-Inducible Factor-1{alpha} to Inhibit Proliferation of Human Endothelial Cells
J. Immunol., July 15, 2008; 181(2): 1052 - 1062.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Yamashita, K. Ohneda, M. Nagano, C. Miyoshi, N. Kaneko, Y. Miwa, M. Yamamoto, O. Ohneda, and Y. Fujii-Kuriyama
Hypoxia-inducible Transcription Factor-2{alpha} in Endothelial Cells Regulates Tumor Neovascularization through Activation of Ephrin A1
J. Biol. Chem., July 4, 2008; 283(27): 18926 - 18936.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
M. Puppo, F. Battaglia, C. Ottaviano, S. Delfino, D. Ribatti, L. Varesio, and M. C. Bosco
Topotecan inhibits vascular endothelial growth factor production and angiogenic activity induced by hypoxia in human neuroblastoma by targeting hypoxia-inducible factor-1{alpha} and -2{alpha}
Mol. Cancer Ther., July 1, 2008; 7(7): 1974 - 1984.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. J. Champion, M. Guinea, V. Dammai, and T. Hsu
Endothelial Function of von Hippel-Lindau Tumor Suppressor Gene: Control of Fibroblast Growth Factor Receptor Signaling
Cancer Res., June 15, 2008; 68(12): 4649 - 4657.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Seifeddine, A. Dreiem, E. Blanc, M.-C. Fulchignoni-Lataud, M.-A. L. F. Belda, F. Lecuru, T. H. Mayi, N. Mazure, V. Favaudon, C. Massaad, et al.
Hypoxia Down-regulates CCAAT/Enhancer Binding Protein-{alpha} Expression in Breast Cancer Cells
Cancer Res., April 1, 2008; 68(7): 2158 - 2165.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
F. Battaglia, S. Delfino, E. Merello, M. Puppo, R. Piva, L. Varesio, and M. C. Bosco
Hypoxia transcriptionally induces macrophage-inflammatory protein-3{alpha}/CCL-20 in primary human mononuclear phagocytes through nuclear factor (NF)-{kappa}B
J. Leukoc. Biol., March 1, 2008; 83(3): 648 - 662.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. A. Carroll and M. Ashcroft
Regulation of Angiogenic Factors by HDM2 in Renal Cell Carcinoma
Cancer Res., January 15, 2008; 68(2): 545 - 552.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. Sathornsumetee, Y. Cao, J. E. Marcello, J. E. Herndon II, R. E. McLendon, A. Desjardins, H. S. Friedman, M. W. Dewhirst, J. J. Vredenburgh, and J. N. Rich
Tumor Angiogenic and Hypoxic Profiles Predict Radiographic Response and Survival in Malignant Astrocytoma Patients Treated With Bevacizumab and Irinotecan
J. Clin. Oncol., January 10, 2008; 26(2): 271 - 278.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. K. Martens, K. M. Kirschner, C. Warnecke, and H. Scholz
Hypoxia-inducible Factor-1 (HIF-1) Is a Transcriptional Activator of the TrkB Neurotrophin Receptor Gene
J. Biol. Chem., May 11, 2007; 282(19): 14379 - 14388.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
I. Kojima, T. Tanaka, R. Inagi, H. Kato, T. Yamashita, A. Sakiyama, O. Ohneda, N. Takeda, M. Sata, T. Miyata, et al.
Protective Role of Hypoxia-Inducible Factor-2{alpha} against Ischemic Damage and Oxidative Stress in the Kidney
J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1218 - 1226.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
T. Shinojima, M. Oya, A. Takayanagi, R. Mizuno, N. Shimizu, and M. Murai
Renal cancer cells lacking hypoxia inducible factor (HIF)-1{alpha} expression maintain vascular endothelial growth factor expression through HIF-2{alpha}
Carcinogenesis, March 1, 2007; 28(3): 529 - 536.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Viemann, M. Schmidt, K. Tenbrock, S. Schmid, V. Muller, K. Klimmek, S. Ludwig, J. Roth, and M. Goebeler
The Contact Allergen Nickel Triggers a Unique Inflammatory and Proangiogenic Gene Expression Pattern via Activation of NF-{kappa}B and Hypoxia-Inducible Factor-1{alpha}
J. Immunol., March 1, 2007; 178(5): 3198 - 3207.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
J. An and M. B. Rettig
Epidermal growth factor receptor inhibition sensitizes renal cell carcinoma cells to the cytotoxic effects of bortezomib
Mol. Cancer Ther., January 1, 2007; 6(1): 61 - 69.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
T. M. Asikainen, N. S. Waleh, B. K. Schneider, R. I. Clyman, and C. W. White
Enhancement of angiogenic effectors through hypoxia-inducible factor in preterm primate lung in vivo
Am J Physiol Lung Cell Mol Physiol, October 1, 2006; 291(4): L588 - L595.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
R. D. Guzy and P. T. Schumacker
Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia
Exp Physiol, September 1, 2006; 91(5): 807 - 819.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Kaluz, M. Kaluzova, and E. J. Stanbridge
Proteasomal Inhibition Attenuates Transcriptional Activity of Hypoxia-Inducible Factor 1 (HIF-1) via Specific Effect on the HIF-1{alpha} C-Terminal Activation Domain
Mol. Cell. Biol., August 1, 2006; 26(15): 5895 - 5907.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. A. Esteban, S. K. Harten, M. G. Tran, and P. H. Maxwell
Formation of Primary Cilia in the Renal Epithelium Is Regulated by the von Hippel-Lindau Tumor Suppressor Protein
J. Am. Soc. Nephrol., July 1, 2006; 17(7): 1801 - 1806.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
X. Zheng, J. L. Ruas, R. Cao, F. A. Salomons, Y. Cao, L. Poellinger, and T. Pereira
Cell-Type-Specific Regulation of Degradation of Hypoxia-Inducible Factor 1{alpha}: Role of Subcellular Compartmentalization
Mol. Cell. Biol., June 15, 2006; 26(12): 4628 - 4641.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. A. Carroll and M. Ashcroft
Role of Hypoxia-Inducible Factor (HIF)-1{alpha} versus HIF-2{alpha} in the Regulation of HIF Target Genes in Response to Hypoxia, Insulin-Like Growth Factor-I, or Loss of von Hippel-Lindau Function: Implications for Targeting the HIF Pathway.
Cancer Res., June 15, 2006; 66(12): 6264 - 6270.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. P. Elvidge, L. Glenny, R. J. Appelhoff, P. J. Ratcliffe, J. Ragoussis, and J. M. Gleadle
Concordant Regulation of Gene Expression by Hypoxia and 2-Oxoglutarate-dependent Dioxygenase Inhibition: THE ROLE OF HIF-1{alpha}, HIF-2{alpha}, AND OTHER PATHWAYS
J. Biol. Chem., June 2, 2006; 281(22): 15215 - 15226.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Okuyama, B. Krishnamachary, Y. F. Zhou, H. Nagasawa, M. Bosch-Marce, and G. L. Semenza
Expression of Vascular Endothelial Growth Factor Receptor 1 in Bone Marrow-derived Mesenchymal Cells Is Dependent on Hypoxia-inducible Factor 1
J. Biol. Chem., June 2, 2006; 281(22): 15554 - 15563.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
O. Aprelikova, M. Wood, S. Tackett, G. V.R. Chandramouli, and J. C. Barrett
Role of ETS Transcription Factors in the Hypoxia-Inducible Factor-2 Target Gene Selection
Cancer Res., June 1, 2006; 66(11): 5641 - 5647.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. A. Esteban, M. G.B. Tran, S. K. Harten, P. Hill, M. C. Castellanos, A. Chandra, R. Raval, T. S. O'Brien, and P. H. Maxwell
Regulation of E-cadherin Expression by VHL and Hypoxia-Inducible Factor.
Cancer Res., April 1, 2006; 66(7): 3567 - 3575.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Dayan, D. Roux, M. C. Brahimi-Horn, J. Pouyssegur, and N. M. Mazure
The Oxygen Sensor Factor-Inhibiting Hypoxia-Inducible Factor-1 Controls Expression of Distinct Genes through the Bifunctional Transcriptional Character of Hypoxia-Inducible Factor-1{alpha}.
Cancer Res., April 1, 2006; 66(7): 3688 - 3698.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. J. Knowles, D. R. Mole, P. J. Ratcliffe, and A. L. Harris
Normoxic Stabilization of Hypoxia-Inducible Factor-1{alpha} by Modulation of the Labile Iron Pool in Differentiating U937 Macrophages: Effect of Natural Resistance-Associated Macrophage Protein 1.
Cancer Res., March 1, 2006; 66(5): 2600 - 2607.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. I. Koukourakis, S. M. Bentzen, A. Giatromanolaki, G. D. Wilson, F. M. Daley, M. I. Saunders, S. Dische, E. Sivridis, and A. L. Harris
Endogenous Markers of Two Separate Hypoxia Response Pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) Are Associated With Radiotherapy Failure in Head and Neck Cancer Patients Recruited in the CHART Randomized Trial
J. Clin. Oncol., February 10, 2006; 24(5): 727 - 735.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. D. Cowden Dahl, B. H. Fryer, F. A. Mack, V. Compernolle, E. Maltepe, D. M. Adelman, P. Carmeliet, and M. C. Simon
Hypoxia-Inducible Factors 1{alpha} and 2{alpha} Regulate Trophoblast Differentiation
Mol. Cell. Biol., December 1, 2005; 25(23): 10479 - 10491.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
G. L. Semenza
Involvement of Hypoxia-Inducible Factor 1 in Pulmonary Pathophysiology
Chest, December 1, 2005; 128(6_suppl): 592S - 594S.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
G. L. Semenza
Involvement of Hypoxia-Inducible Factor 1 in Pulmonary Pathophysiology
Chest, December 1, 2005; 128(6_suppl): 592S - 594S.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. E. Sears and G. Hoppe
Triamcinolone Acetonide Destabilizes VEGF mRNA in Muller Cells under Continuous Cobalt Stimulation
Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 4336 - 4341.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. S. Patel, J.-L. Li, D. Generali, R. Poulsom, D. W. Cranston, and A. L. Harris
Up-regulation of Delta-like 4 Ligand in Human Tumor Vasculature and the Role of Basal Expression in Endothelial Cell Function
Cancer Res., October 1, 2005; 65(19): 8690 - 8697.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Bilton, N. Mazure, E. Trottier, M. Hattab, M.-A. Dery, D. E. Richard, J. Pouyssegur, and M. C. Brahimi-Horn
Arrest-defective-1 Protein, an Acetyltransferase, Does Not Alter Stability of Hypoxia-inducible Factor (HIF)-1{alpha} and Is Not Induced by Hypoxia or HIF
J. Biol. Chem., September 2, 2005; 280(35): 31132 - 31140.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. An and M. B. Rettig
Mechanism of von Hippel-Lindau Protein-Mediated Suppression of Nuclear Factor kappa B Activity
Mol. Cell. Biol., September 1, 2005; 25(17): 7546 - 7556.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. R. Raval, K. W. Lau, M. G. B. Tran, H. M. Sowter, S. J. Mandriota, J.-L. Li, C. W. Pugh, P. H. Maxwell, A. L. Harris, and P. J. Ratcliffe
Contrasting Properties of Hypoxia-Inducible Factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-Associated Renal Cell Carcinoma
Mol. Cell. Biol., July 1, 2005; 25(13): 5675 - 5686.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Smith, L. Gunaratnam, M. Morley, A. Franovic, K. Mekhail, and S. Lee
Silencing of Epidermal Growth Factor Receptor Suppresses Hypoxia-Inducible Factor-2-Driven VHL-/- Renal Cancer
Cancer Res., June 15, 2005; 65(12): 5221 - 5230.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
E. B. Rankin, D. F. Higgins, J. A. Walisser, R. S. Johnson, C. A. Bradfield, and V. H. Haase
Inactivation of the Arylhydrocarbon Receptor Nuclear Translocator (Arnt) Suppresses von Hippel-Lindau Disease-Associated Vascular Tumors in Mice
Mol. Cell. Biol., April 15, 2005; 25(8): 3163 - 3172.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. Wang, D. A. Davis, M. Haque, L. E. Huang, and R. Yarchoan
Differential Gene Up-Regulation by Hypoxia-Inducible Factor-1{alpha} and Hypoxia-Inducible Factor-2{alpha} in HEK293T Cells
Cancer Res., April 15, 2005; 65(8): 3299 - 3306.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. L. Covello, M. C. Simon, and B. Keith
Targeted Replacement of Hypoxia-Inducible Factor-1{alpha} by a Hypoxia-Inducible Factor-2{alpha} Knock-in Allele Promotes Tumor Growth
Cancer Res., March 15, 2005; 65(6): 2277 - 2286.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
V. A.J. Kempf, M. Lebiedziejewski, K. Alitalo, J.-H. Walzlein, U. Ehehalt, J. Fiebig, S. Huber, B. Schutt, C. A. Sander, S. Muller, et al.
Activation of Hypoxia-Inducible Factor-1 in Bacillary Angiomatosis: Evidence for a Role of Hypoxia-Inducible Factor-1 in Bacterial Infections
Circulation, March 1, 2005; 111(8): 1054 - 1062.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
G Eisenhofer, T-T Huynh, K Pacak, F M Brouwers, M M Walther, W M Linehan, P J Munson, M Mannelli, D S Goldstein, and A G Elkahloun
Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome
Endocr. Relat. Cancer, December 1, 2004; 11(4): 897 - 911.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. P. Stolze, Y.-M. Tian, R. J. Appelhoff, H. Turley, C. C. Wykoff, J. M. Gleadle, and P. J. Ratcliffe
Genetic Analysis of the Role of the Asparaginyl Hydroxylase Factor Inhibiting Hypoxia-inducible Factor (HIF) in Regulating HIF Transcriptional Target Genes
J. Biol. Chem., October 8, 2004; 279(41): 42719 - 42725.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Biol.Home page
T. Acker and H. Acker
Cellular oxygen sensing need in CNS function: physiological and pathological implications
J. Exp. Biol., August 15, 2004; 207(18): 3171 - 3188.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
G. L. Semenza
Hydroxylation of HIF-1: Oxygen Sensing at the Molecular Level
Physiology, August 1, 2004; 19(4): 176 - 182.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
N. Takeda, K. Maemura, Y. Imai, T. Harada, D. Kawanami, T. Nojiri, I. Manabe, and R. Nagai
Endothelial PAS Domain Protein 1 Gene Promotes Angiogenesis Through the Transactivation of Both Vascular Endothelial Growth Factor and Its Receptor, Flt-1
Circ. Res., July 23, 2004; 95(2): 146 - 153.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Uchida, F. Rossignol, M. A. Matthay, R. Mounier, S. Couette, E. Clottes, and C. Clerici
Prolonged Hypoxia Differentially Regulates Hypoxia-inducible Factor (HIF)-1{alpha} and HIF-2{alpha} Expression in Lung Epithelial Cells: IMPLICATION OF NATURAL ANTISENSE HIF-1{alpha}
J. Biol. Chem., April 9, 2004; 279(15): 14871 - 14878.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
M. Zimmer, D. Doucette, N. Siddiqui, and O. Iliopoulos
Inhibition of Hypoxia-Inducible Factor Is Sufficient for Growth Suppression of VHL-/- Tumors
Mol. Cancer Res., February 1, 2004; 2(2): 89 - 95.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.